Canada markets closed

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
26.21-0.20 (-0.76%)
At close: 04:00PM EDT
25.11 -1.10 (-4.20%)
After hours: 04:19PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 4.08B
Enterprise Value 3.59B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)9.02
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -12.80

Trading Information

Stock Price History

Beta (5Y Monthly) 1.97
52-Week Change 3-19.28%
S&P500 52-Week Change 3-16.88%
52 Week High 346.16
52 Week Low 319.86
50-Day Moving Average 330.23
200-Day Moving Average 329.45

Share Statistics

Avg Vol (3 month) 3827.83k
Avg Vol (10 day) 3723.96k
Shares Outstanding 5155.75M
Implied Shares Outstanding 6N/A
Float 864.42M
% Held by Insiders 117.70%
% Held by Institutions 182.41%
Shares Short (Aug 30, 2022) 45.54M
Short Ratio (Aug 30, 2022) 44.32
Short % of Float (Aug 30, 2022) 412.11%
Short % of Shares Outstanding (Aug 30, 2022) 43.56%
Shares Short (prior month Jul 28, 2022) 45.09M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-35.97%
Return on Equity (ttm)-74.96%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -279.84M
Net Income Avi to Common (ttm)-279.88M
Diluted EPS (ttm)-1.71
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)531.21M
Total Cash Per Share (mrq)3.58
Total Debt (mrq)89.77M
Total Debt/Equity (mrq)19.83
Current Ratio (mrq)9.52
Book Value Per Share (mrq)3.05

Cash Flow Statement

Operating Cash Flow (ttm)-221.82M
Levered Free Cash Flow (ttm)-124.67M